Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux
Status:
Completed
Trial end date:
2019-03-26
Target enrollment:
Participant gender:
Summary
The aim of the trial is to study the efficacy of adding concomitant chemotherapy
(carboplatin/5FU) to Erbitux-radiotherapy in patients with locally advanced head and neck
cancer.